BiologicalDrug
Panzyga clinical trials
Keep track of what changes. Save the Panzyga studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- Panzyga
- 4
Studies by the year they started
5 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Studies
Open first, then newest update. How each study uses Panzyga is read from its arms, and is right about nine times in ten.
Testing it · 5
- Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent InfectionsRecruitingPhase 3OctapharmaNCT07220915Written as Panzyga, 10% Intravenous Solution
- Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) PatientsRecruitingPhase 3OctapharmaNCT04929236Written as Panzyga
- Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)CompletedPhase 3OctapharmaNCT04502030Written as Panzyga
- Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS)CompletedPhase 3OctapharmaNCT04508530Written as Panzyga
- Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP)TerminatedPhase 4OctapharmaNCT03866798Written as Panzyga
Codes
What other systems call Panzyga · ClinicalTrials.gg INT000658
- MeSH (NLM) C000617884PanzygaOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000617884 | Panzyga | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.